Better Access. Better Lives.
Latest news
- Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors
- Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
- Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)
Who we are
We specialize in making biosimilars – to improve lives by expanding access to affordable biologic medicines. We are purpose-driven and passionate about what we do.
Our approach
We believe that a vertically integrated approach, from cell line development through fill and finish manufacturing, gives us the control, scale and speed needed to achieve our mission. We maintain our singular focus on what we do best while relying on the deep expertise of our partners for commercialization.
Our Pipeline
We are committed to developing and manufacturing high-quality, cost-competitive biosimilars. We continually evaluate additional pipeline opportunities to bring a strategic and robust selection of biologic medicines to patients around the world.
Latest news
Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors
Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)
Join our team
Here at Alvotech, we want our employees to feel inspired in their careers and challenged by interesting and meaningful work. That’s why we are proud of our purpose-driven culture. We are always interested in speaking to passionate, experienced individuals. Are you ready to join our growing team?